Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-May-24 5:40 PM View:  | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 22-May-24 | Market Sale (Planned) | 6,000 | $14.73 | $88,372.20 | (< 1%) 770.88K to 764.88K | 19% |
| 22-May-24 5:40 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 21-May-24 | Market Sale (Planned) | 6,000 | $14.20 | $85,230.00 | (< 1%) 776.88K to 770.88K | 16% |
| 22-May-24 5:40 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 20-May-24 | Market Sale (Planned) | 6,000 | $15.45 | $92,689.20 | (< 1%) 782.88K to 776.88K | 23% |
| 03-May-24 7:12 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 03-May-24 | Market Sale (Planned) | 723 | $14.15 | $10,233.50 | (< 1%) 783.6K to 782.88K | 16% |
| 03-May-24 7:12 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 02-May-24 | Market Sale (Planned) | 6,000 | $14.01 | $84,081.00 | (< 1%) 789.6K to 783.6K | 15% |
| 03-May-24 7:12 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 01-May-24 | Market Sale (Planned) | 175 | $14.03 | $2,456.00 | (< 1%) 789.78K to 789.6K | 15% |
| 05-Apr-24 5:48 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 05-Apr-24 | Market Sale (Planned) | 6,000 | $14.44 | $86,640.00 | (< 1%) 795.78K to 789.78K | 17% |
| 08-Apr-24 4:22 PM View: | Frazier Life Sciences X, L.P. 10% Owner | Hillevax, Inc. (HLVX) | 04-Apr-24 | Market Purchase | 8,850 | $14.50 | $128,325.00 | < 1% 8.54M to 8.54M | (18%) |
| 05-Apr-24 5:48 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 04-Apr-24 | Market Sale (Planned) | 6,000 | $14.71 | $88,245.00 | (< 1%) 801.78K to 795.78K | 19% |
| 05-Apr-24 5:48 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 03-Apr-24 | Market Sale (Planned) | 6,000 | $14.93 | $89,581.80 | (< 1%) 807.78K to 801.78K | 20% |
| 01-Apr-24 4:08 PM View: | McLoughlin Sean Chief Operating Officer | Hillevax, Inc. (HLVX) | 28-Mar-24 | Market Purchase | 1,250 | $16.98 | $21,225.00 | 100% 0 to 1.25K | (30%) |
| 20-Mar-24 6:27 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 20-Mar-24 | Sale (Planned) | 6,000 | $164,221.00 | $985,326,016.00 | (< 1%) 813.78K to 807.78K | |
| 20-Mar-24 6:27 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 19-Mar-24 | Sale (Planned) | 6,000 | $17.42 | $104,492.00 | (< 1%) 819.78K to 813.78K | |
| 20-Mar-24 6:27 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 18-Mar-24 | Private Sale (Planned) | 6,000 | $17.66 | $105,937.00 | (< 1%) 825.78K to 819.78K | |
| 08-Mar-24 6:38 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 08-Mar-24 | Sale (Planned) | 6,000 | $18.66 | $111,959.00 | (< 1%) 831.78K to 825.78K | |
| 08-Mar-24 6:38 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 07-Mar-24 | Sale (Planned) | 6,000 | $18.37 | $110,213.00 | (< 1%) 837.78K to 831.78K | |
| 08-Mar-24 6:38 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 06-Mar-24 | Private Sale (Planned) | 6,000 | $18.95 | $113,701.00 | (< 1%) 843.78K to 837.78K | |
| 22-Feb-24 5:20 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 22-Feb-24 | Market Sale (Planned) | 6,000 | $15.05 | $90,312.00 | (< 1%) 849.78K to 843.78K | 21% |
| 22-Feb-24 5:20 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 21-Feb-24 | Market Sale (Planned) | 6,000 | $14.92 | $89,494.80 | (< 1%) 855.78K to 849.78K | 20% |
| 22-Feb-24 5:20 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 20-Feb-24 | Market Sale (Planned) | 6,000 | $14.88 | $89,271.60 | (< 1%) 861.78K to 855.78K | 20% |
| 14-Feb-24 4:22 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 12-Feb-24 | Market Sale (Planned) | 6,000 | $15.32 | $91,920.60 | (< 1%) 867.78K to 861.78K | 22% |
| 12-Feb-24 7:47 PM View: | Hershberg Robert See Remarks Director | Hillevax, Inc. (HLVX) | 08-Feb-24 | Grant | 174,202 | -- | -- | 18% 965.43K to 1.14M | |
| 12-Feb-24 7:35 PM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 08-Feb-24 | Sale | 3,933 | $14.93 | $58,725.60 | (2%) 218.82K to 214.89K | |
| 12-Feb-24 8:06 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 08-Feb-24 | Sale | 8,866 | $14.93 | $132,383.00 | (1%) 876.64K to 867.78K | |
| 12-Feb-24 7:51 PM View: | Maltbie Shane Chief Financial Officer | Hillevax, Inc. (HLVX) | 08-Feb-24 | Grant | 47,522 | -- | -- | 107% 44.23K to 91.75K | |
| 12-Feb-24 7:47 PM View: | Hershberg Robert See Remarks Director | Hillevax, Inc. (HLVX) | 08-Feb-24 | Sale | 11,597 | $14.93 | $173,161.00 | (1%) 1.14M to 1.13M | |
| 12-Feb-24 7:35 PM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 08-Feb-24 | Grant | 53,632 | -- | -- | 32% 165.19K to 218.82K | |
| 12-Feb-24 8:06 PM View: | Kohli Aditya Director | Hillevax, Inc. (HLVX) | 08-Feb-24 | Grant | 54,898 | -- | -- | 7% 821.74K to 876.64K | |
| 12-Feb-24 7:51 PM View: | Maltbie Shane Chief Financial Officer | Hillevax, Inc. (HLVX) | 08-Feb-24 | Sale | 3,576 | $14.93 | $53,395.00 | (4%) 91.75K to 88.18K | |
| 18-Dec-23 5:34 PM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 15-Dec-23 | Market Sale | 10,000 | $15.50 | $155,000.00 | (6%) 175.19K to 165.19K | 23% |
| 05-Dec-23 4:52 PM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 04-Dec-23 | Market Sale | 10,000 | $14.50 | $145,000.00 | (5%) 185.19K to 175.19K | 18% |
| 05-Dec-23 4:52 PM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 01-Dec-23 | Market Sale | 10,000 | $14.20 | $142,000.00 | (5%) 195.19K to 185.19K | 16% |
| 20-Nov-23 4:53 PM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 17-Nov-23 | Market Sale | 10,000 | $14.00 | $140,000.00 | (5%) 205.19K to 195.19K | 15% |
| 13-Nov-23 5:25 PM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 08-Nov-23 | Market Sale | 5,000 | $13.00 | $65,000.00 | (2%) 210.19K to 205.19K | 8% |
| 23-Jun-23 10:09 AM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 21-Jun-23 | Disposition | 10,000 | $16.11 | $161,100.00 | (5%) 220.19K to 210.19K | 26% |
| 03-Feb-23 4:16 PM View: | Maltbie Shane Chief Financial Officer | Hillevax, Inc. (HLVX) | 01-Feb-23 | Grant | 43,333 | -- | -- | 4820% 0.9K to 44.23K | |
| 03-Feb-23 4:22 PM View: | Borkowski Astrid Chief Medical Officer | Hillevax, Inc. (HLVX) | 01-Feb-23 | Grant | 51,333 | -- | -- | 30% 168.44K to 219.77K | |
| 03-Feb-23 4:17 PM View: | Hershberg Robert President and CEO Director | Hillevax, Inc. (HLVX) | 01-Feb-23 | Grant | 187,966 | -- | -- | 24% 777.46K to 965.43K | |
| 03-Feb-23 4:21 PM View: | Kohli Aditya Chief Operating Officer Director | Hillevax, Inc. (HLVX) | 01-Feb-23 | Grant | 85,466 | -- | -- | 12% 736.28K to 821.74K | |
| 01-Dec-22 5:47 PM View: | Takeda Pharmaceutical Co Ltd 10% Owner | Hillevax, Inc. (HLVX) | 30-Nov-22 | Exercise (in-the money or at-the-money) | 5,883,500 | -- | -- | 700% 840.5K to 6.72M | |
| 03-May-22 4:23 PM View: | Frazier Life Sciences X, L.P. 10% Owner | Hillevax, Inc. (HLVX) | 03-May-22 | Conversion | 2,736,230 | $13.60 | $37,212,800.00 | 68% 4.03M to 6.77M | |
| 03-May-22 4:23 PM View: | Frazier Life Sciences X, L.P. 10% Owner | Hillevax, Inc. (HLVX) | 03-May-22 | Private Purchase | 1,764,710 | $17.00 | $30,000,000.00 | 26% 6.77M to 8.54M |
